Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA study

Abstract Background Sleep impairment is common in rheumatoid arthritis (RA) but has not been extensively studied with wearables and self-observation following treatment. This study investigates the impact of upadacitinib (UPA) on subjective (self-reported) and objective (actigraphy-based) sleep qual...

Descrición completa

Detalles Bibliográficos

Principais autores:	Thomas Hügle, Heino Prillwitz, Godehard Scholz, Diego Kyburz, Jean Dudler, Kristin Schmiedeberg, Laura Zanisi, Melanie D. Harrer Kuster, Pascal S. Roulin, Andrea Rubbert-Roth
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-02-01
Series:	Arthritis Research & Therapy
Assuntos:	Rheumatoid arthritis Sleep Upadacitinib Wearable Remission
Acceso en liña:	https://doi.org/10.1186/s13075-026-03766-1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!